H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 7.9% of adults in Salt Lake City have diagnosed diabetes — 4.1 points below the U.S. 12% figure. Census population 200,133. Utah Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Salt Lake City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Salt Lake City storefront.
Fibrin Matrix Therapy Products in Salt Lake City, UT for clinics & physicians. Fibrin matrix therapy suppo… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Salt Lake City is JF (Noridian Healthcare Solutions) and that adult diabetes here is 7.9% (PLACES 2023), it is selling units, not a program. That is the fibrin matrix therapy conversation we actually have.
National Fibrin Matrix Therapy Products notes (how the product actually works)Three grains, kept separate on purpose. City: Census 200,133 and CDC PLACES crude rates. State: Utah Department of Health & Human Services, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and Noridian Healthcare Solutions LCDs. CDC PLACES (2023, crude) estimates 7.9% of adults in Salt Lake City have diagnosed diabetes — 4.1 points below the U.S. 12% figure.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 7.9% of adults in Salt Lake City have diagnosed diabetes — 4.1 points below the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the fibrin matrix therapy account.
CDC PLACES (2023, crude prevalence) estimates 7.9% of adults — 4.1 points below the U.S. 12% figure. Obesity is 29.5%; arthritis is 18.9%. That is place-level BRFSS modeling, not a clinic census and not a Salt Lake City trial.
It is the Census city-proper count — useful as scale for a city under 250k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
Point-of-care spin, kit handling, and documentation basics. Injection technique, privileging, and ultrasound guidance remain the clinic’s clinical education path in Utah.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
Bring specialty, monthly wound volume, and whether you bill JF FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 7.9% diabetes and 18.9% arthritis for Salt Lake City — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Salt Lake City, UT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Salt Lake City is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Salt Lake City — 4.1 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Utah Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, OR, SD, WA, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Salt Lake City. Useful for joint-program math; still needs a diagnosis and privileging.
No Salt Lake City storefront. Joe Bradley is an active practice owner. fibrin matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.